Home/Bioinorganic Chemistry and Applications/Article Record
Peer-Reviewed Article October 7, 2021

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: Bioinorganic Chemistry and Applications
Publisher: Hindawi Publishing Corporation • Egypt • 1565-3633
DOI: https://doi.org/10.1155/2021/4041415

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can lead to end-stage liver disease needing a liver transplant. Many pharmacological approaches are used to reduce the disease progression in NAFLD. However, current strategies remain ineffective to reverse the progression of NAFLD completely. Employing nanoparticles as a drug delivery system has demonstrated significant potential for improving the bioavailability of drugs in the treatment of NAFLD. Various types of nanoparticles are exploited in this regard for the management of NAFLD. In this review, we cover the current therapeutic approaches to manage NAFLD and provide a review of recent up-to-date advances in the uses of nanoparticles for the treatment of NAFLD.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

61
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.